Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.currproblcancer.2021.100739 http://scihub22266oqcxt.onion/10.1016/j.currproblcancer.2021.100739 33810911!7988448!33810911     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Probl+Cancer 2021 ; 45 (6): 100739 Nephropedia Template TP {{tp|p=33810911|t=2021. Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin s lymphoma: A case report |pdf=|usr=}}{{33810911}} gab.com Text Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin s lymphoma: A case report JO: Curr Probl Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33810911 #FOAvip We describe a case of coronavirus disease 2019 (COVID-19) in a patient with mixed cellularity classical Hodgkin lymphoma (cHL) undergoing brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) therapy. A 43-year-old man presented to our hospital with a complaint of fever, for which he was diagnosed with COVID-19 after a positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and antiviral therapy with favipiravir and ciclesonide was started subsequently. The fever persisted for the first few days of treatment, but his respiratory status was stable, and he became asymptomatic and afebrile on day 9. Although the PCR tests remained positive, he met the updated discharge criteria of the World Health Organization (WHO) on day 12. However, his fever recurred, and his condition worsened on day 16. A chest X-ray showed a new opacity. It is likely that favipiravir and ciclesonide treatment probably did not completely eliminate the virus in the patient, and therefore the infection persisted. We added remdesivir from day 21, and the improvement was remarkable. He was discharged on day 29 after two consecutive PCR test results were negative. PCR tests are not mandatory for the updated WHO discharge criteria. However, even after antiviral therapy, COVID-19 patients with hematologic malignancies may have prolonged active infection with impaired viral excretion. Depending on the background disease and comorbidities, there may be some patient populations for whom it is not appropriate to simply comply with the current discharge criteria. Therefore, more emphasis may be needed on PCR examinations. Twit Text FOAVip Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin s lymphoma: A case report ????Curr Probl Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33810911 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33810911 #FOAvip English Wikipedia <ref>{{Cite pmid|33810911}}</ref> Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin s lymphoma: A case report #MMPMID33810911 Fujii H; Tsuji T; Sugitani M; Matsumoto Y; Yuba T; Tanaka S; Suga Y; Matsuyama A; Goda S; Omura A; Shiotsu S; Takumi C; Ono S; Hiraoka N Curr Probl Cancer 2021[Dec]; 45 (6): 100739 PMID33810911show ga We describe a case of coronavirus disease 2019 (COVID-19) in a patient with mixed cellularity classical Hodgkin lymphoma (cHL) undergoing brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) therapy. A 43-year-old man presented to our hospital with a complaint of fever, for which he was diagnosed with COVID-19 after a positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and antiviral therapy with favipiravir and ciclesonide was started subsequently. The fever persisted for the first few days of treatment, but his respiratory status was stable, and he became asymptomatic and afebrile on day 9. Although the PCR tests remained positive, he met the updated discharge criteria of the World Health Organization (WHO) on day 12. However, his fever recurred, and his condition worsened on day 16. A chest X-ray showed a new opacity. It is likely that favipiravir and ciclesonide treatment probably did not completely eliminate the virus in the patient, and therefore the infection persisted. We added remdesivir from day 21, and the improvement was remarkable. He was discharged on day 29 after two consecutive PCR test results were negative. PCR tests are not mandatory for the updated WHO discharge criteria. However, even after antiviral therapy, COVID-19 patients with hematologic malignancies may have prolonged active infection with impaired viral excretion. Depending on the background disease and comorbidities, there may be some patient populations for whom it is not appropriate to simply comply with the current discharge criteria. Therefore, more emphasis may be needed on PCR examinations. |*COVID-19 Drug Treatment[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Adult[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Antineoplastic Agents/*therapeutic use[MESH] |Antineoplastic Combined Chemotherapy Protocols/*therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Brentuximab Vedotin/therapeutic use[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19/*complications/diagnosis[MESH] |Dacarbazine/therapeutic use[MESH] |Disease Progression[MESH] |Doxorubicin/therapeutic use[MESH] |Hodgkin Disease/*complications/*drug therapy[MESH] |Humans[MESH] |Male[MESH] |Pregnenediones/therapeutic use[MESH] |Pyrazines/therapeutic use[MESH] |Time Factors[MESH]Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for(epmc).pdf DeepDyve Pubget Overpricing